There were different levels of CD34+KDR+ EPC-EXs at different times during ischemic stroke, which may be used as biomarkers for diseases and indicators for the prognosis of and therapeutic efficacy for ischemic stroke (35). The gene discussed is CD34; the disease is ischemic stroke.